Dr Richard Adams

Biography

Professional memberships Chair Ano-rectal subgroup of the National Cancer Research Institute clinical study group (CSG) 2012 – onwards International Executive board member ARCAD Advanced Colorectal cancer database international research group and UK member 2011-present International Rare Cancer Initiative Anal Cancer Group member 2011-present Lead for radiotherapy Quality Assurance for ARISTOTLE/COPERNICUS and TREC trials 2011-present NCRI Colorectal cancer Clinical Studies Group (CSG) member 2010-present National Cancer Research Institute CTRad CSG phase I/II subgroup chair 2014-presetn ESMO scientific committee lower gastrointestinal cancers 2014- present ASCO - member Academic positions 2017-present: Professor in Cancer Clinical trials Cardiff University 2013-2017: Reader in Clinical Oncology Cardiff University 2007-2013: Senior Lecturer in Clinical Oncology Cardiff University 2007-present: Honorary Consultant in Clinical Oncology Velindre NHS Trust 2007-present: Honorary Consultant in Clinical Oncology Cardiff and Vale University Health Board

Research Interest

Richard Adams is Professor and Honorary Consultant Clinical Oncologist at Cardiff University and Velindre Cancer Centre. He is Director of Cancer Trials for the Centre for Trials Research and Director of the Wales Cancer Bank. His clinical practice and research is focused on lower gastrointestinal cancers. He is chair of the National Cancer Research Institute anorectal cancer and CTRad WS2 (UK radiotherapy research) subgroups. He is active in national and international research organisations including IRCI the International Rare Cancer Initiative (for anal cancer) and ARCAD. Richard chairs the biomarker development group for the UK phase III FOCUS4 trial in metastatic colorectal cancer and is Chief investigator for the FOCUS4 D and F trials. He leads on the radiotherapy quality assurance programme for the UK ARISTOTLE and SAILOR trials. He has a role within Wales to engage researchers in translational research and leads work package 3 of the Wales Cancer Research Centre. He oversees collaborative translational research in numerous phase II/ III colorectal cancer trials. He was a founder member of and now chairs the South Wales Sierra Leone Cancer Care link..